A case of leech-associated infection involving an extended-spectrum β-lactamase-producing and extensively drug-resistant Aeromonas isolate
Case report published in Clinical Microbiology and Infection (2018)
Resumen
Reports first leech-therapy infection caused by an extensively drug-resistant Aeromonas producing ESBL — sensitive only to colistin and tigecycline.
Por qué esto importa para la hirudoterapia
Critical XDR Aeromonas case in leech therapy — major safety/antibiotic-prophylaxis red flag.
Citación
A case of leech-associated infection involving an extended-spectrum β-lactamase-producing and extensively drug-resistant Aeromonas isolate.
Floug Q et al. · Clinical microbiology and infection, 2018
Contexto clínico relacionado
Explore cómo esta investigación se conecta con la práctica clínica
Añadido a la biblioteca ASH: May 27, 2026 · Última actualización del sitio: June 18, 2026